The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2026

Filed:

Nov. 13, 2020
Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Evangelos Aktoudianakis, Redwood City, CA (US);

Todd Appleby, San Francisco, CA (US);

Aesop Cho, Mountain View, CA (US);

Zhimin Du, Belmont, CA (US);

Michael Graupe, Pacifica, CA (US);

Juan A. Guerrero, Concord, CA (US);

Salman Y. Jabri, San Francisco, CA (US);

Lateshkumar Thakorlal Lad, Belmont, CA (US);

Paulo A. Machicao Tello, Oakland, CA (US);

Jonathan William Medley, San Mateo, CA (US);

Samuel E. Metobo, Newark, CA (US);

Prasenjit Kumar Mukherjee, South San Francisco, CA (US);

Devan Naduthambi, San Bruno, CA (US);

Gregory Notte, Redwood City, CA (US);

Eric Q. Parkhill, Union City, CA (US);

Barton W. Phillips, San Mateo, CA (US);

Scott Preston Simonovich, San Francisco, CA (US);

Neil H. Squires, San Francisco, CA (US);

Chandrasekar Venkataramani, San Carlos, CA (US);

Peiyuan Wang, San Mateo, CA (US);

William J. Watkins, Saratoga, CA (US);

Jie Xu, Foster City, CA (US);

Kin Shing Yang, San Mateo, CA (US);

Christopher Allen Ziebenhaus, San Francisco, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 213/69 (2006.01); A61K 31/44 (2006.01); A61K 31/444 (2006.01); A61K 31/4545 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07D 213/30 (2006.01); C07D 213/61 (2006.01); C07D 213/64 (2006.01); C07D 213/85 (2006.01); C07D 295/088 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01); C07D 498/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 213/69 (2013.01); A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4545 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 213/30 (2013.01); C07D 213/61 (2013.01); C07D 213/64 (2013.01); C07D 213/85 (2013.01); C07D 295/088 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01); C07D 498/04 (2013.01); C07D 519/00 (2013.01);
Abstract

Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.


Find Patent Forward Citations

Loading…